Hemangiopericytomas in the Central Nervous System: A Multicenter Study of Korean Cases with Validation of the Usage of STAT6 Immunohistochemistry for Diagnosis of Disease

Junjeong Choi,Sung-Hye Park,Shin-Kwang Khang,Yeon-Lim Suh,Sang Pyo Kim,Youn Soo Lee,Hyun Seok Kwon,Seok-Gu Kang,Se Hoon Kim

Hemangiopericytomas in the Central Nervous System: A Multicenter Study of Korean Cases with Validation of the Usage of STAT6 Immunohistochemistry for Diagnosis of Disease

2016

Junjeong Choi
Sung-Hye Park
Shin-Kwang Khang
Yeon-Lim Suh
Sang Pyo Kim
Youn Soo Lee
Hyun Seok Kwon
Seok-Gu Kang
Se Hoon Kim

Background Hemangiopericytoma (HPC) in the central nervous system (CNS) is a rare disease with distinctive biological/clinical characteristics compared with meningioma.

Keywords:

Pathology
Hemangiopericytoma
Meningioma
Rare disease
Solitary fibrous tumor
Disease
Central nervous system
Retrospective cohort study
Survival rate
Medicine
Immunohistochemistry

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations